https://www.selleckchem.com/pr....oducts/liraglutide.h
ive and dynamic monitoring of MDR bacteria, coupled with careful use of antibiotics.Colorectal cancer (CRC) is the third most common cancer and the second leading cause of cancer deaths worldwide. Besides common therapeutic approaches, such as surgery, chemotherapy, and radiotherapy, novel therapeutic approaches, including immunotherapy, have been an advent in CRC treatment. The immunotherapy approaches try to elicit patients` immune responses against tumor cells to eradicate the tumor. Monoclonal antibodies (mAbs) and chimeric anti
Like
Comment
Share
